Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Ebola virus vaccine for adults approved for use in Canada - Global News
  Mon, 25 Sep 2023 18:22 GMT
• NYC spending $28M on 'disease detectives' to prep for potential polio, ebola, COVID outbreaks - New York Post
  Sat, 23 Sep 2023 15:58 GMT
• Parasite that lingers with 'frog Ebola' killing Florida frogs worse than previously thought - Florida Today
  Tue, 26 Sep 2023 09:12 GMT
• Ebola vaccine: Canada approves shot for exposed adults - CTV News
  Mon, 25 Sep 2023 17:54 GMT
• Canada approves Ebola virus vaccine for adults exposed to the deadly disease - CP24
  Mon, 25 Sep 2023 19:26 GMT
• Burning Man flooding triggers false claims of Ebola outbreak, 'national emergency' - The Associated Press
  Tue, 05 Sep 2023 07:00 GMT
• No Ebola, but here's how Burning Man flooding could make people sick - Insider
  Sat, 02 Sep 2023 07:00 GMT
• Rumours of Ebola outbreak at Burning Man Festival - here's why they're false - Sky News
  Mon, 04 Sep 2023 07:00 GMT
• More People Die from Venomous Snakebites Each Year Than Have Ever Died from Ebola - Scientific American
  Tue, 19 Sep 2023 19:46 GMT
• Burning Man was an undeniable disaster. But these conspiracies aren't part of it - The Independent
  Tue, 05 Sep 2023 07:00 GMT
• OSU integrative biology team uses machine learning in newly ... - Oklahoma State University
  Mon, 25 Sep 2023 21:34 GMT
• No, There’s Not An Ebola Outbreak At Burning Man - Forbes
  Sat, 02 Sep 2023 07:00 GMT
• Clinical trials in remote rainforests: how vital Ebola research in DRC ... - Gavi, the Vaccine Alliance
  Wed, 30 Aug 2023 07:00 GMT
• Assessment of healthcare workers' knowledge and attitude on Ebola ... - ReliefWeb
  Tue, 29 Aug 2023 07:00 GMT
• Retrospective Comparison of Nigeria's Emergency Response ... - Cureus
  Tue, 29 Aug 2023 07:00 GMT

• PRO/AH/EDR> Ebola update (44): Burkina Faso ex Cote d'Ivoire, 2nd case, NOT
  Mon, 30 Aug 2021 11:01:25 -0400
  Ebola -- Burkina Faso
  On 22 Aug 2021, the Ministry of Health informed the population of the admission to the Medical Emergencies of the Bogodogo University Hospital (CHU-B) of a 22-year-old patient who had stayed in the Republic of [Cote d'Ivoire]. The diagnostic procedure consisted of sampling analysis at the National Reference Laboratory for Viral Haemorrhagic Fever (LNR-FHV at the Muraz Centre) and the Pasteur Institute of Dakar for confirmation. The results obtained make it possible to permanently rule out

• Negative and ambisense RNA virus ribonucleocapsids: more than protective armor Tue, 26 Sep 2023 06:00:00 -0400
  Negative and ambisense RNA viruses are the causative agents of important human diseases such as influenza, measles, Lassa fever, and Ebola hemorrhagic fever. The viral genome of these RNA viruses consists of one or more single-stranded RNA molecules that are encapsidated by viral nucleocapsid proteins to form a ribonucleoprotein complex (RNP). This RNP acts as protection, as a scaffold for RNA folding, and as the context for viral replication and transcription by a viral RNA polymerase. However,...
• Molecular characterization of the 2022 Sudan virus disease outbreak in Uganda Tue, 26 Sep 2023 06:00:00 -0400
  Uganda experienced five Ebola disease outbreaks caused by Bundibugyo virus (n = 1) and Sudan virus (SUDV) (n = 4) from 2000 to 2021. On 20 September 2022, Uganda declared a fifth Sudan virus disease outbreak in the Mubende district, resulting in 142 confirmed and 22 probable cases by the end of the outbreak declaration on 11 January 2023. The earliest identified cases, through retrospective case investigations, had onset in early August 2022. From the 142 confirmed cases, we performed unbiased...
• Learning from implementation of a COVID case management desk guide and training: a pilot study in Sierra Leone Sun, 24 Sep 2023 06:00:00 -0400
  CONCLUSION: This pilot study demonstrated the relevance and importance of guides adapted to the context, which were able to improve the confidence of health staff to manage their own and the community's fears in the face of a new pandemic and improve their skills. Previous epidemics, particularly Ebola, complicated this by both creating structures that could be revitalised but also assumptions and behaviours that were not adapted to the new disease. Our study documents positive adaptations and...
• Recombinant Lactococcus lactis Expressing Human LL-37 Prevents Deaths from Viral Infections in Piglets and Chicken Sun, 24 Sep 2023 06:00:00 -0400
  Novel antibiotic substitutes are increasingly in demand in the animal husbandry industry. An oral recombinant Lactococcus lactis (L. lactis) expressing human LL-37 (oral LL-37) was developed and its safety and antiviral effectiveness in vivo was tested. In addition to impairing liposome integrity, LL-37 polypeptide from recombinant L. lactis could prevent the host cell infection by a variety of viruses, including recombinant SARS, SARS-CoV-2, Ebola virus, and vesicular stomatitis virus G....
• GRADE concept 6: A novel application of external indirect evidence into GRADE ratings of evidence certainty in Network Meta-analysis Fri, 22 Sep 2023 06:00:00 -0400
  CONCLUSION: Systematic review authors and guideline developers should apply the fundamental logical construction for indirect comparisons and consider compelling external evidence in NMA certainty ratings.
• Prevalence and Factors Related to Post-traumatic Stress Disorder and Depression Symptoms Among Children and Adolescents Survivors and Orphans of Ebola Virus Disease in Democratic Republic of the Congo Eastern Regions During the COVID-19 Pandemic Fri, 22 Sep 2023 06:00:00 -0400
  PURPOSE: Although previous studies have shown a high prevalence of mental health problems among adult Ebola virus disease survivors, no studies have yet been conducted on mental health problems among children and adolescents in affected regions. Consequently, the current study aimed to examine the prevalence and factors associated with depression and post-traumatic stress disorder (PTSD) among children and adolescent survivors and orphans by utilizing a cross-sectional survey following the...
• Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood Fri, 22 Sep 2023 06:00:00 -0400
  Proper disinfection and inactivation of highly pathogenic viruses is an essential component of public health and prevention. Depending on environment, surfaces, and type of contaminant, various methods of disinfection must be both efficient and available. To test both established and novel chemical disinfectants against risk group 4 viruses in our maximum containment facility, we developed a standardized protocol and assessed the chemical inactivation of the two Ebola virus variants Mayinga and...
• Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease Thu, 21 Sep 2023 06:00:00 -0400
  INTRODUCTION: Immune correlates of protection afforded by PHV02, a recombinant vesicular stomatitis (rVSV) vector vaccine against Nipah virus (NiV) disease, were investigated in the African green monkey (AGM) model. Neutralizing antibody to NiV has been proposed as the principal mediator of protection against future NiV infection.
• More People Die From Venomous Snakebites Each Year Than Have Ever Died from Ebola Thu, 21 Sep 2023 06:00:00 -0400
  No abstract
• Effective Infodemic Management: A Substantive Article of the Pandemic Accord Wed, 20 Sep 2023 06:00:00 -0400
  Social media has proven to be valuable for disseminating public health information during pandemics. However, the circulation of misinformation through social media during public health emergencies, such as the SARS (severe acute respiratory syndrome), Ebola, and COVID-19 pandemics, has seriously hampered effective responses, leading to negative consequences. Intentionally misleading and deceptive fake news aims to harm organizations and individuals. To effectively respond to misinformation,...